Streptomyces toxytricini: Difference between revisions
Content deleted Content added
→Further Reading: -vpn link |
|||
| Line 22: | Line 22: | ||
[[Category:Streptomyces|toxytricini]] |
[[Category:Streptomyces|toxytricini]] |
||
{{ |
{{Streptomyces-stub}} |
||
Revision as of 16:31, 4 December 2014
| Streptomyces toxytricini | |
|---|---|
| Scientific classification | |
| Domain: | |
| Phylum: | |
| Order: | |
| Family: | |
| Genus: | |
| Species: | S. toxytricini
|
| Binomial name | |
| Streptomyces toxytricini Preobrazhenskaya & Sveshnikova 1957
| |
Streptomyces toxytricini is a Gram-positive bacterium belonging to the genus Streptomyces. It produces the pancreatic lipase inhibitor lipstatin,[1] of which the antiobesity drug orlistat is a derivative.[2]
References
- ^ Weibel E, Hadvary P, Hochuli E, Kupfer E, Lengsfeld H (1987). "Lipstatin, an inhibitor of pancreatic lipase, produced by Streptomyces toxytricini. I. Producing organism, fermentation, isolation and biological activity". J Antibiot (Tokyo). 40 (8): 1081–5. doi:10.7164/antibiotics.40.1081. PMID 3680018.
{{cite journal}}: CS1 maint: multiple names: authors list (link) - ^ Barbier P, Schneider F (1987). "Syntheses of tetrahydrolipstatin and absolute configuration of tetrahydrolipstatin and lipstatin". Helvetica Chimica Acta. 70 (1): 196–202. doi:10.1002/hlca.19870700124.
Further Reading
- Zhu, Tingheng; Wang, Lingfei; Wang, Weixia; Hu, Zhongce; Yu, Meilan; Wang, Kun; Cui, Zhifeng (April 3, 2014). "Enhanced production of lipstatin from Streptomyces toxytricini by optimizing fermentation conditions and medium". Journal of General and Applied Microbiology. 60 (3): 106-111. doi:10.2323/jgam.60.106. PMID 25008166.
{{cite journal}}:|access-date=requires|url=(help)
 | This Streptomyces-related article is a stub. You can help Wikipedia by expanding it. |